Cardiovascular disease (CVD), particularly atherosclerosis‐associated CVD, is a major
cause of long‐term mortality after liver transplantation (LT). The liver is central in lipid …

NAFLD is common after liver transplantation (LT) and is associated with an increased
metabolic burden. Currently, there is a paucity of investigations into the treatment of post-LT …

Metabolic flexibility is the ability to match biofuel availability to utilization. Reduced metabolic
flexibility, or lower fatty acid (FA) oxidation in the fasted state, is associated with obesity. The …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of increased liver enzyme
levels and has rapidly become the leading cause of chronic liver disease. 1, 2 NAFLD is …

Our data about pathogenesis of hepatic steatosis after liver transplantation is scarce. This
study aimed to investigate the association between serum adipokines and insulin resistance …

Background: Information on the risk factors, particularly kidney function, and impact of long-
term cardiovascular events (CVE) after liver transplantation (LT) remains scarce. Methods …

Cardiovascular disease (CVD) is an important cause of mortality among liver transplantation
(LT) recipients; however, the data on CVD risk stratification following LT are limited. Thus …

Background. As our previous publications show, it is feasible to reverse type 1 diabetes
(T1D) without insulin in multiple mouse models, through transplantation of embryonic brown …

Metabolic flexibility is the ability to match biofuel availability to utilization and is inversely
associated with increased metabolic burden among liver transplant (LT) recipients. The …

Introduction The prevalence of coronary artery disease (CAD) is high among patients with
cirrhosis; however, the impact of it on cardiovascular disease (CVD) is not known. The aim of …